Published in J Addict Dis on January 01, 1991
Diffusion of the D.A.R.E and syringe exchange programs. Am J Public Health (2006) 1.20
Secondary syringe exchange among injection drug users. J Urban Health (2003) 1.12
A pilot syringe exchange program in Washington, DC. Am J Public Health (1994) 0.96
A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs. Drug Alcohol Depend (2011) 0.78
HIV infection among people who inject drugs: the challenge of racial/ethnic disparities. Am Psychol (2013) 0.78
A physical map of the human genome. Nature (2001) 12.39
Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet (1999) 8.91
HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA (1989) 6.68
HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet (1996) 5.43
p140mDia, a mammalian homolog of Drosophila diaphanous, is a target protein for Rho small GTPase and is a ligand for profilin. EMBO J (1997) 5.03
Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J Cell Biol (1998) 4.91
Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA (1995) 4.88
Structural interventions: concepts, challenges and opportunities for research. J Urban Health (2006) 4.70
Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS (1987) 3.78
Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users. Ann Intern Med (1985) 3.63
Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. JAMA (1994) 3.41
Building leadership capacity and future leaders in operational research in low-income countries: why and how? Int J Tuberc Lung Dis (2011) 3.40
Sociometric risk networks and risk for HIV infection. Am J Public Health (1997) 3.29
HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS (1987) 3.24
Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health (1995) 3.24
International epidemiology of HIV and AIDS among injecting drug users. AIDS (1992) 3.19
Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav (1988) 3.14
The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Soc Sci Med (1994) 3.05
A randomized trial of an interim methadone maintenance clinic. Am J Public Health (1991) 2.99
Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. Am J Epidemiol (2000) 2.95
AIDS health education for intravenous drug users. Health Educ Q (1986) 2.92
The Union and Médecins Sans Frontières approach to operational research. Int J Tuberc Lung Dis (2011) 2.91
HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention. Rev Infect Dis (1988) 2.91
Applying the ICMJE authorship criteria to operational research in low-income countries: the need to engage programme managers and policy makers. Trop Med Int Health (2013) 2.78
HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health (2000) 2.74
AIDS and self-organization among intravenous drug users. Int J Addict (1987) 2.73
Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium. Am J Epidemiol (1995) 2.66
The AIDS epidemic among blacks and Hispanics. Milbank Q (1987) 2.54
A novel partner for the GTP-bound forms of rho and rac. FEBS Lett (1995) 2.52
High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 2.38
Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. Am J Public Health (1998) 2.28
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health (2001) 2.21
A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City. Science (1988) 2.20
Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction (2001) 2.17
Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. Am J Public Health (2000) 2.09
Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health (2001) 2.02
Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution. Sex Transm Infect (2006) 2.00
HIV and HCV infection among injecting drug users. Mt Sinai J Med (2000) 1.96
Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci Med (1996) 1.93
Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done. Public Health Rep (1998) 1.92
Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.87
Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. AIDS (2001) 1.80
Harm reduction--a framework for incorporating science into drug policy. Am J Public Health (1995) 1.75
Using medical services claims to assess injuries in the elderly: sensitivity of diagnostic and procedure codes for injury ascertainment. J Clin Epidemiol (2000) 1.74
Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol (2001) 1.73
Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs. Am J Public Health (1995) 1.72
Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS (1993) 1.72
The epidemic of acquired immunodeficiency syndrome (AIDS) and suggestions for its control in drug abusers. J Subst Abuse Treat (1984) 1.70
Geographic proximity, policy and utilization of syringe exchange programmes. AIDS Care (1999) 1.70
AIDS and the transition to illicit drug injection--results of a randomized trial prevention program. Br J Addict (1992) 1.68
Measuring the effects of an international health professions faculty development fellowship: the FAIMER Institute. Med Teach (2010) 1.68
Recommendations for control and prevention of human immunodeficiency virus (HIV) infection in intravenous drug users. Ann Intern Med (1989) 1.65
HIV among drug injectors: the epidemic and the response. AIDS Care (1991) 1.64
Stigmatized drug use, sexual partner concurrency, and other sex risk network and behavior characteristics of 18- to 24-year-old youth in a high-risk neighborhood. Sex Transm Dis (2001) 1.62
The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society. J Med Screen (2005) 1.61
High compliance with a hepatitis B virus vaccination program among intravenous drug users. J Infect Dis (1991) 1.60
Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users. AIDS (1987) 1.60
Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS (1991) 1.60
Hypersensitivity reactions to streptokinase in patients with high pre-treatment antistreptokinase antibody and neutralisation titres. Eur Heart J (1993) 1.59
Chlamydia species as a cause of community-acquired pneumonia in Canada. Eur Respir J (2003) 1.59
Harm reduction: a public health response to the AIDS epidemic among injecting drug users. Annu Rev Public Health (1993) 1.57
Impact of waiting time on the quality of life of patients awaiting coronary artery bypass grafting. CMAJ (2001) 1.57
Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial. Cancer Res (2000) 1.55
The protective effect of AIDS-related behavioral change among injection drug users: a cross-national study. WHO Multi-Centre Study of AIDS and Injecting Drug Use. Am J Public Health (1996) 1.51
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51
AIDS and i.v. drug use. Science (1989) 1.51
Self-reports of HIV risk behavior by injecting drug users: are they reliable? Addiction (1995) 1.49
Practicing medicine without borders: tele-consultations and tele-mentoring for improving paediatric care in a conflict setting in Somalia? Trop Med Int Health (2012) 1.47
Drug scene roles and HIV risk. Addiction (1998) 1.45
Shooting galleries and AIDS: infection probabilities and 'tough' policies. Am J Public Health (1990) 1.43
Outreach to injecting drug users and female sexual partners of drug users on the lower east side of New York City. Br J Addict (1992) 1.42
AIDS and the new drug injector. Nature (1989) 1.41
Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. NIDA Res Monogr (1995) 1.41
Effects of outreach intervention on risk reduction among intravenous drug users. AIDS Educ Prev (1990) 1.37
Keeping it together: stigma, response, and perception of risk in relationships between drug injectors and crack smokers, and other community residents. AIDS Care (2005) 1.37
The study of transitions in the route of drug use: the route from one route to another. Br J Addict (1992) 1.36
Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996. J Acquir Immune Defic Syndr (1999) 1.36
An ambulance referral network improves access to emergency obstetric and neonatal care in a district of rural Burundi with high maternal mortality. Trop Med Int Health (2013) 1.33
Intravenous drug use and the heterosexual transmission of the human immunodeficiency virus. Current trends in New York City. N Y State J Med (1987) 1.32
HIV risk behaviours of current sex workers attending syringe exchange: the experiences of women in five US cities. AIDS Care (1999) 1.32
Implications of directly observed therapy in tuberculosis control measures among IDUs. Public Health Rep (1994) 1.30